Uguz B, Aydin A: Intraosseous lipoma of the fifth metatarsal: a case report. .J Foot Ankle Surg 43::119. ,2004. .
Ozdemir H, Bozgeyik Z, Kocakoc E, et al: MRI findings of intraosseous lipoma: case report. .Magn Reson Imaging 22::281. ,2004. .
Hatori M, Hosaka M, Ehara S, et al: Imaging features of intraosseous lipomas of the calcaneus. .Arch Orthop Trauma Surg 121::429. ,2001. .
Propeck T, Bullard MA, Lin J, et al: Radiologic-pathologic correlation of intraosseous lipomas. .AJR Am J Roentgenol 175::673. ,2000. .
Marx RE, Carlson ER, Eichstaedt RM, et al: Platelet-rich plasma: growth factor enhancement for bone grafts. .Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85::638. ,1998. .
Weinraub GM, Cheung C: Efficacy of allogenic bone implants in a series of consecutive elective foot procedures. .J Foot Ankle Surg 42::86. ,2003. .
Sammarco VJ, Chang L: Modern issues in bone graft substitutes and advances in bone tissue technology. .Foot Ankle Clin 7::19. ,2002. .
Michelson JD, Curl LA: Use of demineralized bone matrix in hindfoot arthrodesis. .Clin Orthop Relat Res 325::203. ,1996. .
Reddi AH: Bone morphogenetic proteins: from basic science to clinical applications. .J Bone Joint Surg Am 83: (suppl 1):S1. ,2001. .
Friedlaender GE, Perry CR, Cole JD, et al: Osteogenic protein-1 (bone morphogenic protein-7) in the treatment of tibial nonunions. .J Bone Joint Surg Am 83: (suppl 1):S151. ,2001. .
Iwata H, Sakano S, Itoh T, et al: Demineralized bone matrix and native bone morphogenetic protein in orthopaedic surgery. .Clin Orthop Relat Res 395::99. ,2002. .
Damien CJ, Parsons JR: Bone graft and bone graft substitutes: a review of current technology and applications. .J Appl Biomater 2::187. ,1991. .
Blitch E, Pachuda N, Karlock L, et al: “Bone Grafts” in McGlamry’s Comprehensive Textbook of Foot and Ankle Surgery, Vol II, ed by AS Banks, MS Downey, DE Martin, et al, p 1465, Lippincott Williams & Wilkins, New York. ,2001. .
Cornell CN: Osteoconductive materials and their role as substitutes for autogenous bone grafts. .Orthop Clin North Am 30::591. ,1999. .
Jiang SD, Jiang LS, Dai LY: Surgical treatment of calcaneal fractures with use of β-tricalcium phosphate ceramic grafting. .Foot Ankle Int 29::1015. ,2008. .
Scheer JH, Adolfsson LE: Tricalcium phosphate bone substitute in corrective osteotomy of the distal radius. .Injury 40::262. ,2009. .
Burns PR, Scanlan RL, Zgonis T, et al: Pathologic conditions of the heel: tumors and arthritides. .Clin Podiatr Med Surg 22::115. ,2005. .
Kilgore WB, Parrish WM: Calcaneal tumors and tumor-like conditions. .Foot Ankle Clin 10::541. ,2005. .
Radl R, Andreas L, Machacek F, et al: Intraosseous lipoma: retrospective analysis of 29 patients. .Int Orthop 28::374. ,2004. .
Osher L, Shook J, Lo K: “Tumors,” in McGlamry’s Comprehensive Textbook of Foot and Ankle Surgery, Vol II, ed by AS Banks, MS Downey, DE Martin, et al, p 1369, Lippincott Williams & Wilkins, New York. ,2001. .
Weinfel G, Yu G, Good J: Intraosseous lipoma of the calcaneus: a review and report of four cases. .J Foot Ankle Surg 41::398. ,2002. .
Intraosseous lipoma is a rare bone tumor that may be encountered in clinical practice. It is benign and is described as a well-defined, radiolucent lesion that must be differentiated from other lytic lesions. Most of these lesions may be treated without surgery; however, when surgery is needed, the classic approach involves curettage and packing using autologous bone grafts, allografts, or synthetic bone substitutes. This article reports two cases using a synthetic bone substitute, TheriLok, to fill the void made from surgical curettage of the intraosseous lipoma. Both patients tolerated the TheriLok bone substitute without developing adverse reactions and precluded the need for a secondary donor site. (J Am Podiatr Med Assoc 100(6): 487–492, 2010)